# Study of CHO-A04 in Advanced Solid Tumors

> **NCT07049458** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Cho Pharma Inc.** · enrollment: 62 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** CHO-A04

## Key facts

- **NCT ID:** NCT07049458
- **Lead sponsor:** Cho Pharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2027-10-01
- **Final completion:** 2028-10-01
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2025-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07049458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07049458, "Study of CHO-A04 in Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07049458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*